In streptozotocin-induced diabetic mice, it is either in vitro bioengineering of antral gastric cells, or in vivo reprogramming of antral gastric cells with the PMN cocktail into insulin secreting organoids can reverse hyperglycemia [94]. The gene discussed is INS; the disease is Hyperglycemia.